Background illustration for clinical trials search

Paid Clinical Trials High Point

Discover 1,729 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)

for
Acute Myeloid Leukemia
Location: Chapel Hill NC, Columbus OH, Dallas TX, Aurora CO
Sponsor: Alice Mims

Sex: All

Age: 18+

Code: NCT05401097

Phase2, Recruiting

STRIDE Biorepository

for
Anemia, Sickle Cell
Location: Chapel Hill NC, Durham NC, Charlottesville VA,
Sponsor: Emory University

Sex: All

Age: 15 - 40

Code: NCT02843347

Recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed Multiple Myeloma, Refractory Multiple Myeloma
Location: Chapel Hill NC, Atlanta GA, Detroit MI, Rochester NY,
Sponsor: Opna Bio LLC

Sex: All

Age: 18+

Code: NCT06433947

Phase1, Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Chapel Hill NC, Savannah GA, Towson MD, Centerville OH,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase3, Recruiting

Consumer Perceptions of Alcoholic Beverages

for
Health Behavior
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 21 - 70+

Code: NCT07226271

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults

for
Obesity, Multiple Chronic Conditions
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 65 - 70+

Code: NCT06044571

Recruiting

Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry

for
Turner Syndrome
Location: Chapel Hill NC, Washington DC, Columbus OH,
Sponsor: University of Colorado, Denver

Sex: Female

Age: 0+

Code: NCT05052606

Recruiting

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

for
Idiopathic Short Stature
Location: Chapel Hill NC, Columbia SC, Washington D.C. DC,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 3 - 11

Code: NCT06382155

Phase2, Recruiting

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

for
Type 2 Diabetes
Location: Chapel Hill NC, Columbia SC, Greenville SC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 10 - 17

Code: NCT06739122

Phase3, Recruiting

Optimal Ventilation for Cardiac Arrest

for
Cardiac Arrest (CA)
Location: Chapel Hill NC, Richmond VA, Atlanta GA, Columbus OH,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07114510

Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

for
Hematologic Malignancies
Location: Chapel Hill NC, Greenville SC, Newnan GA, Birmingham AL,
Sponsor: Sellas Life Sciences Group

Sex: All

Age: 12+

Code: NCT04588922

Phase1, Phase2, Recruiting

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

for
AChR-Ab Seropositive Generalized Myasthenia Gravis,
Location: Chapel Hill NC, Durham NC, Chattanooga TN, Columbus OH,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07284420

Phase2, Recruiting

Rehabilitation Outcomes Study

for
Cancer, Malignant Tumor
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06674889

Recruiting

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

for
Indolent Lymphomas, Lymphoma, Chronic Lymphocytic Leukemia,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06860880

Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Chapel Hill NC, Columbus OH, Nashville TN,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 13 - 70+

Code: NCT06533579

Phase1, Phase2, Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Chapel Hill NC, Salem VA, Atlanta GA, Pittsburgh PA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07221149

Phase2, Phase3, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Chapel Hill NC, Durham NC, West Columbia SC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase3, Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Chapel Hill NC, Atlanta GA, Baltimore MD, Pittsburgh PA,
Sponsor: Corvus Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06561048

Phase3, Recruiting

mHealth for Early Psychosis Caregivers in Statewide Program Outreach

for
Caregiver, Caregiver Distress,
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18+

Code: NCT07225179

Recruiting

A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

for
Multiple Myeloma, Monoclonal Gammopathy of Renal Significance
Location: Chapel Hill NC, Basking Ridge NJ, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06083922

Phase2, Recruiting